Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Hospital-Acquired Infection Control Market Grown from 2024 to 2025?

The size of the market for controlling infections acquired in hospitals has consistently enlarged in the past few years. It is expected to expand from $34.59 billion in 2024 to $35.86 billion in 2025, with a compound annual growth rate (CAGR) of 3.7%. The historic growth can be credited to factors such as rising resistance to antibiotics, increasing awareness, strict regulatory measures, the global spread of infectious diseases, and initiatives aimed at patient safety.

What Growth Rate Is Anticipated for the Hospital-Acquired Infection Control Market in the Coming Years?

In the coming years, the hospital-acquired infection control market is expected to witness robust growth. The market size is projected to reach $44.42 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. Key drivers of growth during the forecast period include the emergence of multi-drug resistant pathogens, mitigation strategies for pandemics, heightened surveillance and monitoring, implementation of antimicrobial stewardship programs, and international collaboration. The forecast period also sees the trend of adopting real-time location systems (RTLS), utilizing artificial intelligence (AI) for surveillance, a shift towards single-use and disposable devices, a focus on staff training and education, as well as increased use of disinfection technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

Who Are the Leading Companies in the Hospital-Acquired Infection Control Market?

Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

What Are the Key Drivers of the Hospital-Acquired Infection Control Market?

The spike in cases of COVID-19 is predicted to fuel the expansion of the hospital-acquired infection control market. COVID-19 is a viral infection resulting from the SARS-CoV-2 virus. The pandemic has escalated the demand for hospital-acquired infection control products and services that highlight personal hygiene and facilitate the manufacturing of infection control medical supplies. For example, the World Health Organization, a specialized United Nations agency based in Switzerland, reported that as of 8th August 2022, global COVID-19 cases reached a staggering 581.6 million. Thus, the amplification of COVID-19 cases is stimulating the growth of the hospital-acquired infection control market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp

What Are the Key Market Segments in the Hospital-Acquired Infection Control Industry?

The hospital-acquired infection control market covered in this report is segmented –

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products

2) By Technology: Phenotypic Methods, Genotypic Methods

3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases

4) By Application: Disease Testing, Drug-Resistance Testing

5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Subsegments:

1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers

2) By Disinfectors: Washer Disinfectors, Automated Disinfectors

3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors

4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems

5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)

6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds

7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software

8) By Other Products: Cleaning Equipment, Air Purification Systems

What Are the Latest Trends in the Hospital-Acquired Infection Control Market?

Top-tier companies engaged in the hospital-acquired infection control market are concentrating on the development of innovative technological solutions, like AI systems, for early sepsis identification to improve patient results by accelerating diagnosis and treatment. An AI system for sepsis recognition represents cutting-edge technological tools using artificial intelligence and machine learning patterns to spot initial indications of sepsis in individuals. For instance, Prenosis Inc., a health clinic from the United States, was granted FDA marketing approval for the Sepsis ImmunoScore in April 2024. This was the inaugural AI-controlled system built to predict sepsis, a potentially fatal condition causing serious complications. This groundbreaking instrument promotes early discovery by analyzing real-time data, enabling healthcare practitioners to take swift and efficient action. The incorporation of AI aims to assist rather than substitute medical teams in decision-making processes, thereby enhancing patient outcomes and lowering healthcare expenditures.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

What Are the Key Regional Markets in the Hospital-Acquired Infection Control Industry?

North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694

This Report Delivers Insight On:

1. How big is the hospital-acquired infection control market, and how is it changing globally?

2. Who are the major companies in the hospital-acquired infection control market, and how are they performing?

3. What are the key opportunities and risks in the hospital-acquired infection control market right now?

4. Which products or customer segments are growing the most in the hospital-acquired infection control market?

5. What factors are helping or slowing down the growth of the hospital-acquired infection control market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model